Allspring Global Investments Holdings LLC Grows Stake in Balchem Co. (NASDAQ:BCPC)

Allspring Global Investments Holdings LLC increased its holdings in Balchem Co. (NASDAQ:BCPC) by 2.6% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 85,424 shares of the basic materials company’s stock after buying an additional 2,203 shares during the period. Allspring Global Investments Holdings LLC owned 0.26% of Balchem worth $13,151,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Signaturefd LLC boosted its position in shares of Balchem by 123.0% during the 4th quarter. Signaturefd LLC now owns 165 shares of the basic materials company’s stock valued at $25,000 after acquiring an additional 91 shares during the last quarter. GAMMA Investing LLC bought a new stake in Balchem during the fourth quarter valued at approximately $56,000. Truist Financial Corp grew its stake in Balchem by 52.0% in the 4th quarter. Truist Financial Corp now owns 4,158 shares of the basic materials company’s stock worth $619,000 after buying an additional 1,422 shares in the last quarter. Russell Investments Group Ltd. grew its stake in Balchem by 3.1% in the 4th quarter. Russell Investments Group Ltd. now owns 35,263 shares of the basic materials company’s stock worth $5,245,000 after buying an additional 1,067 shares in the last quarter. Finally, Mission Wealth Management LP bought a new position in shares of Balchem in the 4th quarter worth $223,000. Institutional investors own 87.91% of the company’s stock.

Balchem Stock Up 0.4 %

Shares of BCPC opened at $172.47 on Friday. Balchem Co. has a 1 year low of $110.74 and a 1 year high of $186.03. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.83 and a quick ratio of 1.79. The stock has a 50 day simple moving average of $166.87 and a two-hundred day simple moving average of $157.03. The firm has a market cap of $5.59 billion, a P/E ratio of 48.72, a P/E/G ratio of 5.63 and a beta of 0.68.

Balchem (NASDAQ:BCPC) last announced its quarterly earnings data on Friday, July 26th. The basic materials company reported $0.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.95 by $0.03. The company had revenue of $234.08 million during the quarter, compared to analysts’ expectations of $241.26 million. Balchem had a net margin of 12.52% and a return on equity of 10.94%. On average, analysts forecast that Balchem Co. will post 3.91 earnings per share for the current fiscal year.

Insider Buying and Selling at Balchem

In other news, SVP Gunsteren Job Leonard Van sold 7,750 shares of Balchem stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $180.05, for a total value of $1,395,387.50. Following the transaction, the senior vice president now owns 8,540 shares in the company, valued at $1,537,627. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 1.25% of the company’s stock.

Analyst Upgrades and Downgrades

BCPC has been the subject of a number of research analyst reports. HC Wainwright lifted their price objective on shares of Balchem from $170.00 to $185.00 and gave the stock a “buy” rating in a report on Wednesday, July 31st. StockNews.com downgraded Balchem from a “buy” rating to a “hold” rating in a research report on Monday, July 29th.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.